Wednesday, August 18, 2021 7:42:21 PM
Big explosion after hours here.
Recent CHRS News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/27/2026 08:12:23 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/20/2026 12:59:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/20/2026 12:26:45 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/14/2026 09:20:44 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/09/2026 09:26:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/09/2026 08:56:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 08:40:39 PM
- Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/09/2026 08:15:00 PM
- Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 • GlobeNewswire Inc. • 03/02/2026 02:30:00 PM
- Coherus Oncology to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/23/2026 02:30:00 PM
- Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock • GlobeNewswire Inc. • 02/17/2026 09:11:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 09:05:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2026 10:10:53 PM
- Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 02/13/2026 02:18:21 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/12/2026 09:08:22 PM
- Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 02/12/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 01:40:28 PM
- Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks • PR Newswire (Canada) • 01/27/2026 03:50:00 PM
- Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks • PR Newswire (US) • 01/27/2026 03:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 09:39:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 10:27:26 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/23/2026 10:26:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 01:50:42 AM
- Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape • PR Newswire (Canada) • 01/16/2026 01:00:00 PM

